This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2006-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Idstein, DE (2006)
- Huenstetten, DE (2014)
Company Filing History:
Years Active: 2006-2014
Title: Robert Hagenkoetter: Innovator in Pharmaceutical Chemistry
Introduction
Robert Hagenkoetter is a notable inventor based in Huenstetten, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for preparing complex compounds. With a total of 2 patents to his name, Hagenkoetter's work is instrumental in advancing treatments for various medical conditions.
Latest Patents
Hagenkoetter's latest patents include a process for preparing [4,6-bis-dimethylamino-2-[4-(4-trifluoromethylbenzoylamino)benzyl]pyrimidin-5-yl]acetic acid. This invention relates to a method for synthesizing a compound that holds potential therapeutic benefits. Additionally, he has developed a process for preparing macrocyclic compounds, which are crucial in the treatment of hepatitis C virus (HCV) infections. These compounds are recognized as potent active agents in combating this viral infection.
Career Highlights
Robert Hagenkoetter is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves extensive research and development, focusing on innovative solutions in drug formulation and synthesis. His expertise in pharmaceutical chemistry has positioned him as a valuable asset to his team and the industry.
Collaborations
Hagenkoetter has collaborated with several esteemed colleagues, including Michael Schul and Joerg Brandenburg. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in pharmaceutical research.
Conclusion
Robert Hagenkoetter's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his commitment to advancing medical science. His work continues to impact the treatment of significant health challenges, showcasing the importance of innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile